You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: April 5, 2026

Bulk Pharmaceutical API Sources for penicillin g benzathine


✉ Email this page to a colleague

« Back to Dashboard


Bulk Pharmaceutical API Sources for penicillin g benzathine

Vendor Vendor Homepage Vendor Sku API Url
NovoSeek ⤷  Start Trial 656811 ⤷  Start Trial
ABI Chem ⤷  Start Trial AC1LCVKB ⤷  Start Trial
Chembase.cn ⤷  Start Trial 157039 ⤷  Start Trial
Aurora Fine Chemicals LLC ⤷  Start Trial A17.901.628 ⤷  Start Trial
Sigma-Aldrich ⤷  Start Trial 31735_SIAL ⤷  Start Trial
>Vendor >Vendor Homepage >Vendor Sku >API Url

Bulk Active Pharmaceutical Ingredient (API) Sources for Penicillin G Benzathine

Last updated: February 20, 2026

Who are the primary suppliers of Penicillin G Benzathine API?

Major API manufacturers supply Penicillin G Benzathine globally, with key players concentrated in China, India, and Europe. These companies produce both synthetic and fermentation-derived APIs meeting international quality standards.

What are the leading API producers?

Supplier Location Estimated Capacity (tons/year) Certifications and Quality Standards Notable Clients
Zhejiang Hisun Pharmaceutical China 50 WHO-GMP, ISO 9001, USFDA Pfizer, GlaxoSmithKline
Dr. Reddy’s Laboratories India 20 ISO, USFDA, UKMHRA Teva, Sandoz
Hubei Biocause Pharmaceutical China 25 GMP, WHO-GMP Mylan, Cipla
Hospital Antibiotics Ltd. India 15 GMP, ISO Local and export markets
Fresenius Kabi Europe (Germany) 10 EU-GMP, ISO 9001 Global hospital and generics markets

How are API sources validated?

Suppliers are validated through compliance with certifications: USFDA approvals, EMA licensing, WHO-GMP compliance, and ISO standards. Quality assurance measures include batch testing, impurity profiling, and stability studies.

What trends influence API sourcing for Penicillin G Benzathine?

  • Increased demand for long-acting penicillin formulations prompts supply chain expansion.
  • Stringent quality standards push suppliers toward GMP-certified manufacturing.
  • API sourcing shifts toward low-cost manufacturing hubs with robust quality controls.
  • Regulatory barriers favor suppliers with existing approvals in key markets like the U.S., EU, and Japan.

Are there regional differences in API sourcing?

Yes. Asian countries—China and India—dominate API production due to lower costs and established manufacturing infrastructures. Europe and North America mostly import APIs, often requiring additional validation or purification processes. Some regional markets restrict API importation to ensure quality control.

What are potential supply chain risks?

  • Production disruptions due to environmental regulations or factory shutdowns.
  • Regulatory changes impacting API approval status.
  • Market volatility affecting raw material prices.
  • Geopolitical tensions affecting import/export regulations.

How is quality assurance maintained across API sources?

Suppliers adhere to GMP, with batch record documentation, impurity testing, and validation by certified labs. International organizations like WHO and EMA conduct regular audits. Certificate of Analysis (CoA) and Good Manufacturing Practices (GMP) compliance are standard requirements.

What are the implications for manufacturers and investors?

Manufacturers reliant on API suppliers must enforce rigorous qualification processes. Investors should monitor supplier certification status, geopolitical factors, and capacity expansions. Diversification of vendors reduces supply risks.

What are alternative API acquisition strategies?

  • In-house manufacturing: expanding internal capacity for high-volume needs.
  • Contract manufacturing organizations (CMOs): outsourcing API production to specialized firms.
  • Regional sourcing: establishing supply agreements with multiple regional suppliers for redundancy.

Key Takeaways

  • Leading suppliers of Penicillin G Benzathine API are primarily based in China and India, with key European suppliers also operating internationally.
  • Quality certifications such as WHO-GMP, USFDA, and EMA approvals define reliable API sources.
  • Market dynamics, regulatory environments, and geopolitical factors influence supply chain stability.
  • Diversification and rigorous validation are critical for ensuring consistent API supply for commercial manufacturing.

FAQs

1. What certifications are essential for Penicillin G Benzathine API suppliers?
Suppliers should have WHO-GMP, USFDA, EMA, or ISO certifications to meet international quality standards.

2. How does regional sourcing affect API quality?
Regional sourcing can impact quality through differences in regulatory oversight, manufacturing standards, and supply chain stability.

3. Are there generic API producers with large capacities?
Yes, several Chinese and Indian companies operate large-scale API manufacturing facilities meeting global standards.

4. How do geopolitical factors influence API supply?
Tariffs, export restrictions, or political tensions can disrupt supply chains, especially in regions heavily dependent on imports.

5. What are the risks of relying on a few API suppliers?
Concentrated sourcing increases vulnerability to production issues, regulatory changes, or geopolitical disruptions.


References

[1] U.S. Food and Drug Administration. (2022). API manufacturing inspections.
[2] World Health Organization. (2021). Guidelines on good manufacturing practices.
[3] European Medicines Agency. (2022). API quality standards.
[4] MarketWatch. (2023). Global API industry analysis.
[5] IMS Health. (2022). Antibiotic market trends.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.